thymine has been researched along with Carcinoma, Anaplastic in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trifluridine/tipiracil (FTD/TPI) shows promising antitumor activity in heavily pretreated patients with advanced biliary tract carcinoma, including patients with 5-fluorouracil refractory tumors." | 9.34 | Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma. ( Ahn, DH; Alberts, SR; Bekaii-Saab, TS; Borad, MJ; Chakrabarti, S; Durgin, LM; Fruth, B; Hartgers, ML; Liu, MC; Mahipal, A; McWilliams, RR; Ou, FS; Walkes, RL; Wessling, J; Zemla, TJ, 2020) |
| "To investigate the behaviour of total plasma homocysteine (tHcy) and its most common genetic determinant defect, the methylenetetrahydrofolate reductase C677T (C677TMTHFR) polymorphism in patients with early stage colorectal carcinoma." | 7.73 | Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. ( Battistelli, S; Bing, C; Roviello, F; Stefanoni, M; Vittoria, A, 2006) |
| "Trifluridine/tipiracil (FTD/TPI) shows promising antitumor activity in heavily pretreated patients with advanced biliary tract carcinoma, including patients with 5-fluorouracil refractory tumors." | 5.34 | Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma. ( Ahn, DH; Alberts, SR; Bekaii-Saab, TS; Borad, MJ; Chakrabarti, S; Durgin, LM; Fruth, B; Hartgers, ML; Liu, MC; Mahipal, A; McWilliams, RR; Ou, FS; Walkes, RL; Wessling, J; Zemla, TJ, 2020) |
| "To investigate the behaviour of total plasma homocysteine (tHcy) and its most common genetic determinant defect, the methylenetetrahydrofolate reductase C677T (C677TMTHFR) polymorphism in patients with early stage colorectal carcinoma." | 3.73 | Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. ( Battistelli, S; Bing, C; Roviello, F; Stefanoni, M; Vittoria, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, S | 1 |
| Zemla, TJ | 1 |
| Ahn, DH | 1 |
| Ou, FS | 1 |
| Fruth, B | 1 |
| Borad, MJ | 1 |
| Hartgers, ML | 1 |
| Wessling, J | 1 |
| Walkes, RL | 1 |
| Alberts, SR | 1 |
| McWilliams, RR | 1 |
| Liu, MC | 1 |
| Durgin, LM | 1 |
| Bekaii-Saab, TS | 1 |
| Mahipal, A | 1 |
| Chen, Y | 1 |
| Wang, DD | 1 |
| Wu, YP | 1 |
| Su, D | 1 |
| Zhou, TY | 1 |
| Gai, RH | 1 |
| Fu, YY | 1 |
| Zheng, L | 1 |
| He, QJ | 1 |
| Zhu, H | 1 |
| Yang, B | 1 |
| LANGEN, P | 1 |
| VENKER, P | 1 |
| HEIDELBERGER, C | 1 |
| BOOHAR, J | 1 |
| BIRNIE, GD | 1 |
| DVORAK, O | 1 |
| ELIS, J | 1 |
| JELINEK, J | 1 |
| KAFKA, V | 1 |
| MUSIL, J | 1 |
| SCHUBERT, J | 1 |
| Battistelli, S | 1 |
| Vittoria, A | 1 |
| Stefanoni, M | 1 |
| Bing, C | 1 |
| Roviello, F | 1 |
| Vlak, JM | 1 |
| Rozijn, RH | 1 |
| Spies, F | 1 |
| Nielsen, HR | 1 |
| Nyholm, K | 1 |
| Sjölin, KE | 1 |
1 trial available for thymine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Topics: Biliary Tract; Carcinoma; Humans; Pyrrolidines; Thymine; Trifluridine; Uracil | 2020 |
7 other studies available for thymine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
Topics: Aminoquinolines; Antigens, CD; Blotting, Western; Cadherins; Carcinoma; Cell Line, Tumor; Cell Movem | 2017 |
[ON THE INCORPORATION OF BROMOURACIL INTO THE DESOXYRIBONUCLEIC ACID OF TUMOR-BEARING MICE BY ADMINISTRATION OF BROMOURACIL AND DESOXYGUANOSINE].
Topics: Animals; Bromouracil; Carcinoma; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Mice; Nucleosides; Re | 1963 |
FLUORINATED PYRIMIDINES. XXII. EFFECTS OF VARIOUS COMPOUNDS ON THE INCORPORATION OF (14C)FORMATE INTO DNA THYMINE IN SUSPENSIONS OF EHRLICH ASCITES CELLS.
Topics: Animals; Antineoplastic Agents; Ascites; Carbon Isotopes; Carcinoma; Carcinoma, Ehrlich Tumor; DNA; | 1964 |
COMPARISON OF THYMINALKYLAMINE AND ENDOXAN EFFECT ON ADVANCED GYNECOLOGICAL CARCINOMAS IN A CONTROLLED CLINICAL TRIAL.
Topics: Antineoplastic Agents; Carcinoma; Cyclophosphamide; Drug Therapy; Female; Genital Neoplasms, Female; | 1965 |
Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma.
Topics: Aged; Carcinoma; Cell Proliferation; Colorectal Neoplasms; Cytosine; Female; Genotype; Homocysteine; | 2006 |
Localization of adenovirus DNA replication in KB cells.
Topics: Adenoviridae; Autoradiography; Carbon Radioisotopes; Carcinoma; Cell Fractionation; Cell Line; Cell | 1975 |
Beta-aminoisobutyric acid in urine from patients with urothelial tumours.
Topics: Adult; Aged; Aminoisobutyric Acids; Carcinoma; Carcinoma, Squamous Cell; Female; Follow-Up Studies; | 1971 |